Sign in

CIK 0001665988

  • Accelerated filer
  • Emerging growth company

Bioventus Inc.

Sign in to watch
Ticker
BVS
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
810980861
Phone
+1 919-474-6700
Business address
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703
  1. 4 Planned sale SVP & CFO sold 4,000 shares at $4.75 ($19,000)
  2. 4 Planned sale SVP & General Counsel sold 3,054 shares at $4.75 ($14,507)
  3. 4 Planned sale SVP & Chief Compliance Officer sold 1,325 shares at $4.75 ($6,294)
  4. 4 Exercise or conversion SVP & CFO acquired 13,000 shares (option exercise)
  5. 4 Exercise or conversion SVP & General Counsel acquired 9,925 shares (option exercise)
  6. 4 Exercise or conversion SVP & Chief Compliance Officer acquired 4,300 shares (option exercise)
  7. 4 Open-market sale SVP & CFO sold 5,541 shares at $5.39 ($29,853)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market sale SVP & General Counsel sold 3,125 shares at $5.46 ($17,063)
  12. 4 Open-market sale SVP & Chief Compliance Officer sold 1,217 shares at $5.46 ($6,645)
  13. 4 Exercise or conversion SVP & General Counsel acquired 8,886 shares (option exercise)
  14. 4 Exercise or conversion SVP & Chief Compliance Officer acquired 3,456 shares (option exercise)
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 4/A Other disposition Director disposed of 2,604,264 shares (other)
  18. 3/A Insider 3/A
  19. 4 Open-market buy Interim CEO bought 39,885 shares at $4.14 ($165,076)
  20. 4 Other acquisition Director acquired 41,369 shares (other)

Page 6 of 13 · 251 filings